【Ka'idodin Tsarin】

2019-nCOV IgG Antibody Assay Reagent Kit (CMIA) shine - mataki na rigakafi ta amfani da fasahar magnetic particle chemiluminescence. Yana iya ƙayyadadden ƙayyadaddun kasancewar ƙwayoyin rigakafin - 2019-nCoVIgG a cikin jinin mutum ko plasma.

Yayin amsawar, mataki na farko shine haɗin furotin ta hanyar haɗa samfurin tare da ƙaƙƙarfan barbashi na paramagnetic wanda aka lulluɓe da antigen na furotin na 2019-nCoV. Bayan wankewa, ana ƙara alkaline phosphataselabeled murine anti - ɗan adam IgG monoclonal antibody an ƙara a mataki na biyu don samar da ƙwayar maganadisu-nucleoprotein_anti-2019-nCoV - IgG_murine-anti-IgG- ALP - cakuda amsawar enzyme. Bayan wani sake zagayowar wanka, ana ƙara substrate na alkaline phosphatase zuwa gaurayar dauki. Sakamakon abin da ya haifar da chemiluminescence ana auna shi a cikin raka'o'in haske na dangi (RLU). Ƙaddamar da maganin - 2019-nCoV - IgG antibody a cikin samfurin yayi daidai da adadin raka'a haske na dangi (RLU) na cakuda. Don haka ana iya amfani da sakamakon don gano wanzuwar IgG a cikin samfurin da taimako don sanin ko majinyacin ya kamu da cutar ta 2019-nCoV.